THC:NYE-Tenet Healthcare Corporation (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 133.31

Change

0.00 (0.00)%

Market Cap

USD 1.59B

Volume

1.99M

Analyst Target

USD 30.18
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Tenet Healthcare Corp is a health care services company. The Company, together with its subsidiaries, operates healthcare delivery networks in urban and suburban markets in the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-17 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+3.85 (+1.22%)

USD 81.54B
DVA DaVita HealthCare Partners Inc

-0.09 (-0.06%)

USD 12.59B
UHS Universal Health Services Inc

+0.38 (+0.21%)

USD 12.40B
EHC Encompass Health Corp

-0.62 (-0.61%)

USD 10.06B
CHE Chemed Corp

+5.30 (+0.96%)

USD 8.24B
CON Concentra Group Holdings Paren..

+0.08 (+0.34%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.43 (-2.87%)

USD 2.59B
NHC National HealthCare Corporatio..

-1.14 (-1.12%)

USD 1.90B
AGL agilon health Inc

+0.13 (+3.78%)

USD 1.41B
AMN AMN Healthcare Services Inc

+0.77 (+3.34%)

USD 1.05B

ETFs Containing THC

RJMG First Trust Exchange-Trad.. 2.61 % 0.00 %

-0.20 (0.13%)

USD 0.01B
FXH First Trust Health Care A.. 2.34 % 0.63 %

+1.38 (+0.13%)

USD 1.05B
FHH:CA First Trust AlphaDEX US H.. 2.33 % 0.77 %

+0.06 (+0.13%)

CAD 0.01B
XMMO Invesco S&P MidCap Moment.. 2.29 % 0.39 %

-1.17 (0.13%)

USD 4.68B
XMHQ Invesco S&P MidCap Qualit.. 2.12 % 0.25 %

-0.77 (0.13%)

USD 6.19B
SHRT Tidal ETF Trust 1.46 % 0.00 %

-0.02 (0.13%)

USD 0.01B
ABCS Alpha Blue Capital US Sma.. 1.38 % 0.00 %

+0.04 (+0.13%)

USD 0.01B
NHYB:CA NBI High Yield Bond ETF 1.05 % 0.00 %

-0.10 (0.13%)

CAD 1.07B
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.66 % 0.00 %

+0.10 (+0.13%)

USD 0.20B
SJNK:LSE SSgA SPDR ETFs Europe I p.. 0.58 % 0.00 %

-0.04 (0.13%)

N/A
GVLU Tidal ETF Trust 0.50 % 0.00 %

-0.04 (0.13%)

USD 0.18B
BSJN 0.00 % 0.42 %

N/A

N/A
HYG iShares iBoxx $ High Yiel.. 0.00 % 0.49 %

+0.06 (+0.13%)

N/A
HYND 0.00 % 0.48 %

N/A

N/A
JKL iShares Morningstar Small.. 0.00 % 0.30 %

N/A

N/A
MDYV SPDR® S&P 400 Mid Cap Va.. 0.00 % 0.15 %

-0.30 (0.13%)

N/A
SHYL Xtrackers Short Duration .. 0.00 % 0.20 %

-0.16 (0.13%)

USD 0.15B
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.25 %

+0.02 (+0.13%)

USD 0.32B
HYUP Xtrackers High Beta High .. 0.00 % 0.35 %

+0.03 (+0.13%)

USD 0.01B
BSJQ Invesco BulletShares 2026.. 0.00 % 0.42 %

+0.02 (+0.13%)

USD 0.97B
SHYG iShares 0-5 Year High Yie.. 0.00 % 0.30 %

+0.01 (+0.13%)

USD 6.55B
SJB ProShares Short High Yiel.. 0.00 % 0.95 %

N/A

USD 0.05B
HYLB Xtrackers USD High Yield .. 0.00 % 0.20 %

+0.04 (+0.13%)

USD 3.46B
HYLV 0.00 % 0.40 %

N/A

N/A
BSJR Invesco BulletShares 2027.. 0.00 % 0.00 %

+0.02 (+0.13%)

USD 0.40B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.61% 64% D 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.61% 64% D 72% C
Trailing 12 Months  
Capital Gain 46.61% 91% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.61% 87% B+ 91% A-
Trailing 5 Years  
Capital Gain 299.85% 100% F 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 299.85% 100% F 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 74.68% 96% N/A 96% N/A
Dividend Return 74.68% 96% N/A 96% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 97.96% 26% F 9% A-
Risk Adjusted Return 76.23% 91% A- 84% B
Market Capitalization 1.59B 90% A- 88% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 4.43 82% 91%
Price/Book Ratio 3.48 42% 27%
Price / Cash Flow Ratio 5.63 57% 58%
Price/Free Cash Flow Ratio 3.25 81% 75%
Management Effectiveness  
Return on Equity 59.56% 89% 97%
Return on Invested Capital 13.43% 77% 75%
Return on Assets 6.99% 85% 86%
Debt to Equity Ratio 925.50% 11% 4%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.